Searchable abstracts of presentations at key conferences in endocrinology

ea0094p40 | Bone and Calcium | SFEBES2023

Importance of Evidence-based management of Primary Hyperparathyroidism

Ahmed Nabeel , Hatton Rebecca , Harris Laura , Tabasum Maria , Clarke-Burns Rossana , Brotherton Sophie , Srinivasshankar Upendram

Background: Primary Hyperparathyroidism (PHPT) is the leading cause of hypercalcaemia. Early diagnosis and management is important to prevent long term complications. National institute of clinical excellence (NICE) published guidelines on diagnosis and management of Primary Hyperparathyroidism and we sought to compare our practice with the NICE guideline (NG 132).Methods: This was a retrospective observational study of ...

ea0094p67 | Metabolism, Obesity and Diabetes | SFEBES2023

The effect of snack foods containing rare sugars on glycaemic response, gut hormones and satiety in healthy UK adults

Smith Alison , Avery Amanda , Ford Rebecca , Goux Aurelie , Mukherjee Neil , Yang Qian , Jethwa Preeti

Dietary guidelines in the UK and worldwide recommend reducing the quantity of free sugars in the diet. The consumption of foods high in free sugars can lead to postprandial hyperglycaemia and hyperinsulinemia, which have been implicated in the development of metabolic diseases including type 2 diabetes and obesity. Rare sugars (naturally occurring monosaccharides which hardly exist in nature) have been found to suppress the postprandial elevation in blood glucose and improve g...

ea0095p21 | Diabetes 1 | BSPED2023

Don’t forget bone health: Increased fracture risk in type 1 diabetes

Moon Rebecca , Curtis Elizabeth , D'Angelo Stefania , Raisi-Estabragh Zahra , Cooper Cyrus , Harvey Nicholas

Objectives: Fracture risk is increased in individuals with diabetes mellitus, but how this is related to bone mineral density (BMD), adiposity, inflammation, disease duration and diabetic complications is less well understood. We aimed to investigate associations between type 1 (T1DM) and type 2 (T2DM) diabetes and incident fracture in a large population study.Methods: UK Biobank is a population study incorporating indiv...

ea0095p126 | Gonadal, DSD and Reproduction 2 | BSPED2023

A case of 46, XY differences of sex development (DSD) due to FKBP4 deficiency: A novel candidate of androgen insensitivity syndrome?

Balagamage Chamila , Igbokwe Rebecca , Robinson Hannah , McCarthy Liam , Chandran Harish , Godber Caroline , Mohamed Zainaba , Idkowiak Jan

Introduction: FKBP prolyl isomerase 4, encoded by the gene FKBP4, is a member of the FK506-binding protein family and is presumed to be a regulator of the androgen receptor (AR) pathway. Mutations in FKBP4 have been proposed to cause Androgen Insensitivity Syndrome (AIS), with only one case reported in the literature so far.Aim: To report the clinical, biochemical and genetic findings in an infant with 46, XY DSD a homoz...

ea0098o1 | Other | NANETS2023

Integrating advance care planning into nursing work-flow

Lister RN Michael , OCN BSN, , Adrian Cherie , Brassfield Rebecca , Lindsay NP. Sheila

Background: UCSF Cancer Center is committed to offering all patients information on Advance Directives; however, many patients do not have their wishes well-documented in their EMR. Our clinic has implemented a workflow for introducing advance care planning discussion into treatment teaching sessions. We have begun to share this workflow throughout the cancer center. Many patients in our clinic have metastatic disease and are treated for months to years by our team. It is impo...

ea0077op4.4 | Metabolism, Obesity and Diabetes | SFEBES2021

Audit of Clinical Outcomes with Dexamethasone in Patients Hospitalised with COVID-19

Narendranathan Divani , Richards Molly , Cassin-Scott Rebecca , Chia Eng Pei , Distaso Walter , Tan Tricia , Izzy-Engbeaya Chioma , Salem Victoria

Background: Dexamethasone significantly improved outcomes in patients requiring supplementary oxygen and in ventilated patients with COVID-19 in the RECOVERY trial. Consequently, dexamethasone is now routinely used in these patients. However, dysglycaemia is commonly associated with steroid use and is an established risk factor for poorer outcomes in COVID-19. In this study, we aimed to elucidate the effect of dexamethasone use in patients hospitalised with COVID-19 in a real-...

ea0077p186 | Metabolism, Obesity and Diabetes | SFEBES2021

Predictors of adverse outcomes in COVID-19: A retrospective cohort study comparing the first two waves of COVID-19 hospital admissions in London, with a focus on diabetes

Hashmi Durreshahwar , Shaikhali Yusuf , Cassin-Scott Rebecca , Eng Pei , Distaso Walter , Tan Tricia , Salem Victoria , Izzy-Engbeaya Chioma

Introduction: Diabetes has been associated with poorer outcomes with COVID-19 infection, but precise predictors of mortality in patients with diabetes remain unclear. We assessed predictors of adverse outcomes in patients hospitalised with COVID-19 in Imperial College Healthcare NHS Trust (ICHNT) hospitals during the first and second waves of COVID-19 to determine if outcomes for patients with diabetes have evolved with new variants and treatments.Method...

ea0081ep87 | Adrenal and Cardiovascular Endocrinology | ECE2022

Managing Immune checkpoint inhibitors and adrenal insufficiency in acute setting

Bashir Mahamud , Ramachandran Kirtanya , Volmy Rebecca , Williams Alexanderia , Elonu Akunna , Elekwa Gloria , Fahal Lamis , Rehmani Hassan , Roy Homagni , Mlawa Gideon

The introduction of immune checkpoint inhibitors (ICIs) in clinical management of cancer has had an undeniable impact in management of cancer patients. Currently there are several ICIs are used across Europe including but not limited to, pembrolizumab, atezolizumab, and ipilimumab. Even though their clinical efficacy is reputable, they have the potential of causing serious immunotherapy-related adverse events’ (irADRs) in several organ systems including endocrine organs. ...

ea0081ep625 | General Endocrinology | ECE2022

The development of a GLP protocol for the measurement of 17β-estradiol and testosterone in the H295R steroidogenesis assay, Test No 456

Murray Carol , McIntyre Angela , McKeever Connor , White Rebecca , McBrinn Rachel , Light Victoria , Brown Susan , Robinson Aron , Clark Graeme , Bingham Tilly

Regulators are concerned about the potential for environmental chemicals such as agrochemicals and their metabolites to perturb hormone systems. This has led to recommendations for the testing of potential endocrine disrupting chemicals1. The Steroidogenesis H295R assay is an in vitro cell model used to investigate compound effects on steroid hormone biosynthesis, specifically 17β-estradiol (E2) and testosterone (T). The human H295R adreno-carcinoma ce...

ea0050oc2.5 | Clinical Highlights | SFEBES2017

Additional value of 4D-CT in patients with primary hyperparathyroidism and negative conventional imaging; a reason to change primary imaging modality in patients over 60?

Alkemade Gonnie , Sifontes-Dubon Mildred , Bhatt Dhruti , Smith David , Duguid Rebecca , Straiton Jack , Dymot Jane , Graveling Alex , Abraham Prakash

Introduction: Minimally invasive surgical treatment of primary hyperparathyroidism (PHPT) requires optimal preoperative localisation imaging. Parathyroid four-dimensional CT (4D-CT) has been reported to provide greater sensitivity than MIBI-SPECT/CT in localizing parathyroid adenomas. We analysed the additional value of 4D-CT in our cohort of PHPT patients.Materials and methods: Patients who attended our parathyroid clinic between February 2016 and April...